Following unanimous votes by a committee of independent advisors last week, the Food and Drug Administration approved booster doses of the COVID-19 vaccines produced by Moderna and Johnson & Johnson.
In a similar decision, the FDA approved boosters that are not the same as the vaccination used to immunise people against COVID-19. As an example, a person who received a Johnson & Johnson vaccination may obtain a booster from Moderna or Pfizer-BioNTech.
The regulatory changes pave the way for more widespread usage of boosters. The FDA approved a booster dose of the Pfizer COVID-19 vaccine in September.
“The available data suggest waning immunity in some populations who are fully vaccinated,” said the FDA’s acting commissioner, Dr. Janet Woodcock, in a statement. “The availability of these authorized boosters is important for continued protection against COVID-19 disease.”
On Thursday, a committee of advisers to the Centers for Disease Control and Prevention is scheduled to meet to discuss COVID-19 vaccine booster shots and make recommendations on their use. The CDC director makes the final call on vaccine guidelines. After the CDC issues its guidance, the rollout can begin officially.
Sleep is often regarded as a luxury in today’s fast-paced world, but scientific research continuously…
Heart disease remains one of the leading causes of death worldwide, and in India, cardiovascular…
Delhi is witnessing a sharp rise in flu cases, particularly Influenza B and H1N1 (commonly…
In early February 2025, a tragic incident occurred in Eluru, Andhra Pradesh, where a 61-year-old…
Holi, the festival of colors, is one of the most vibrant and joyous celebrations in…
In a major development, the U.S. Food and Drug Administration (FDA) has issued recalls for…